Two Sigma Securities, LLC Mainz Biomed N.V. Transaction History

Two Sigma Securities, LLC

  • $716 Million
  • Q4 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$0.2 - $0.48 $4,703 - $11,287
23,515 New
23,515 $5,000

Others Institutions Holding MYNZ

# of Institutions
1
Shares Held
10.9K
Call Options Held
0
Put Options Held
0
View Full List

About MAINZ BIOMED N.V.

MYNZ Quotes by TradingView
  • Ticker MYNZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 14,483,000
  • Market Cap $83.1M
  • Description
  • Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments...
More about MYNZ
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email